ArticleScientific reports2025
Association between muscle-specific strength and inflammatory biomarkers in community-dwelling older women: a cross-sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The Global Leadership Initiative on Sarcopenia (GLIS) has released recommendations on the use of muscle-specific strength (MSS) in the assessment of sarcopenia. MSS is considered the measurement of force per unit of muscle mass and has been recommended for comprehensive assessment of muscle tissue and assessment of sarcopenia in the older. While biomarkers have been associated with sarcopenia's pathophysiology and its diagnostic, the association between inflammatory markers and MSS in older people remains understudied. Therefore, this study aimed to evaluate the association between MSS and the concentrations of a panel of inflammatory biomarkers in community-dwelling older women. Seventy-one older women participated in this study, with Dual X-ray Absorptiometry used to assess lean muscle mass and the Jamar dynamometer employed to measure handgrip strength. The concentrations of IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, adiponectin, leptin, resistin, IFN, TNF, sTNFr-1, and sTNFr-2 were measured using flow cytometry and ELISA. Spearman correlation and linear regression analyses were conducted to evaluate the relationships between the variables, with a significance level set at 5%. The analyses revealed significant correlations between muscle-specific strength and the concentrations of IL-5 (ρ = -0.408), IL-6 (ρ = -0.258), IL-8 (ρ = -0.309) and sTNFr-2 (ρ = -0.390) in this sample. The association analysis showed the optimal model explaining variations in muscle-specific strength included IL-5 and sTNFr-2 (R: 0.47; R² 0.20; p = 0.02). These findings suggest a pro-inflammatory component contributing to the loss of muscle-specific strength in community-dwelling older women. Furthermore, they provide insights into the pathophysiology of sarcopenia and identify promising biomarkers that may be useful in screening strategies and early diagnosis of this condition in older adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.